6 October 2003 Photodynamic therapy (ALA-PDT) in the treatment of pathological states of the cornea
Author Affiliations +
Proceedings Volume 5229, Laser Technology VII: Applications of Lasers; (2003) https://doi.org/10.1117/12.520607
Event: Laser Technology VII: Applications of Lasers, 2002, Szczecin, Poland
Each year an increasing amount of research is published on the use of photodynamic therapy in medicine. The most recent research has focused mostly on the use of photosensitizer called vertoporphyrin (Visudyne) is the treatment of subretinal neovascularization in age-related macular degeneration (AMD) or myopia, following a substantial amount of ophthalmology research mostly experimental on the application of the method in diagnosis and treatment of some eye tumors. In the Department of Ophthalmology of Polish Medical University in Warsaw, PDT was used as supplementary method in a selected group of patients with chronic virus ulcer of the cornea and keratopathies. During the treatment 5-aminolevulinic acid (5-ALA) was applied in ointment form as a photosensitizer activated with light wave of 633 nm. It appears, on the basis of the results obtained, that photodynamic therapy (ALA-PDT) may become in the future a valuable supplement to the methods being used at the present treating pathological states of the cornea.
© (2003) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Iwona Switka-Wieclawska, Iwona Switka-Wieclawska, Tadeusz Kecik, Tadeusz Kecik, Miroslaw Kwasny, Miroslaw Kwasny, Alfreda Graczyk, Alfreda Graczyk, } "Photodynamic therapy (ALA-PDT) in the treatment of pathological states of the cornea", Proc. SPIE 5229, Laser Technology VII: Applications of Lasers, (6 October 2003); doi: 10.1117/12.520607; https://doi.org/10.1117/12.520607

Back to Top